Literature DB >> 11513153

Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules.

J C Boyington1, A G Brooks, P D Sun.   

Abstract

The recognition of class I MHC molecules by killer cell immunoglobulin-like receptors (KIR) constitutes an integral part of immune surveillance by the innate immune system. To understand the molecular basis of this recognition, the structures of several members of this superfamily have been determined. Despite their functional diversity, members of this superfamily share many conserved structural features. A central question is how these receptors recognize their ligands. The recent determination of the crystal structure of KIR2DL2 in complex with HLA-Cw3 has revealed the molecular mechanisms underpinning this interaction, which ultimately modulates the cytolytic activity of natural killer cells. While the recognition of MHC molecules by KIR is characterized by a number of unique features, some unexpected similarities with T-cell receptor recognition of MHC molecules are also observed. The detailed interactions between KIR2DL2 and HLA-Cw3 and their functional implications will be reviewed here.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11513153     DOI: 10.1034/j.1600-065x.2001.1810105.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  35 in total

1.  Complex expression of natural killer receptor genes in single natural killer cells.

Authors:  Zaheed Husain; Chester A Alper; Edmond J Yunis; Devendra P Dubey
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

2.  Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.

Authors:  Hugo G Hilton; Luca Vago; Anastazia M Older Aguilar; Achim K Moesta; Thorsten Graef; Laurent Abi-Rached; Paul J Norman; Lisbeth A Guethlein; Katharina Fleischhauer; Peter Parham
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

3.  Origin and evolution of the chicken leukocyte receptor complex.

Authors:  Nikolas Nikolaidis; Izabela Makalowska; Dimitra Chalkia; Wojciech Makalowski; Jan Klein; Masatoshi Nei
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

4.  Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor.

Authors:  Zhiru Yang; Pamela J Bjorkman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-15       Impact factor: 11.205

Review 5.  Can we make a better match or mismatch with KIR genotyping?

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT).

Authors:  Felix A Deuss; Benjamin S Gully; Jamie Rossjohn; Richard Berry
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

Review 7.  KIRigami: the case for studying NK cell receptors in SIV+ macaques.

Authors:  Benjamin Bimber; David H O'Connor
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

8.  Dynamics of free versus complexed β2-microglobulin and the evolution of interfaces in MHC class I molecules.

Authors:  Chee-Seng Hee; Monika Beerbaum; Bernhard Loll; Martin Ballaschk; Peter Schmieder; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  Immunogenetics       Date:  2012-12-11       Impact factor: 2.846

9.  Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands.

Authors:  Ketevan Gendzekhadze; Paul J Norman; Laurent Abi-Rached; Thorsten Graef; Achim K Moesta; Zulay Layrisse; Peter Parham
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-16       Impact factor: 11.205

10.  Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection.

Authors:  Jane H Wang; Xin Zheng; Xiaogang Ke; M Tevfik Dorak; Jingjing Shen; Basmattee Boodram; Maurice O'Gorman; Kenneth Beaman; Scott J Cotler; Ronald Hershow; Lijun Rong
Journal:  Virol J       Date:  2009-05-01       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.